• FOUNDED 2009

Overview

The Neuroendocrine Tumours Group is concerned with the management of neuroendocrine tumours (NETs). NETs are composed of neuroendocrine cells that produce and secrete regulatory hormones and are present throughout the nervous and endocrine systems. NETs can occur at many sites in the body, but they are most common in the digestive system.  NETs are uncommon tumours that have many unusual features.

This group recognises the difficulty in providing quality multidisciplinary care for patients suffering from NETs. It aims to provide a platform for discussing NET-related issues and to advocate for the care of patients with NETs.

Group information

[Chair] Dr David Chan, Royal North Shore Hospital, NSW

Dr Gabby Cehic, The Queen Elizabeth Hospital, SA

Ms Erin Laing, Peter MacCallum Cancer Centre, VIC

A/Prof Michael Michael, Peter MacCallum Cancer Centre, VIC

Prof Tim Price, The Queen Elizabeth Hospital, SA

Ms Kate Wakelin, NeuroEndocrine Cancer Australia, VIC

A/Prof David Wyld, Royal Brisbane Hospital, QLD

Read the Neuroendocrine Tumour Group Terms of Reference

Read the AGM Minutes from 1 November 2023

Read the AGM Minutes from 22 November 2021

Read the AGM Minutes from 23 November 2020

Group Chair

Group Chair Image
Group Chair

David Chan

Neuroendocrine Tumours Group Chair